Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Enzlein

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
The EMBO Journal|October 19, 2023
APP substrate ectodomain defines amyloid-β peptide length by restraining γ-secretase processivity and facilitating product releaseMatthias Koch, Thomas Enzlein, Shu-Yu Chen, et al.
Alzheimer'S Research & Therapy|November 27, 2025
The relationship between amyloid-β peptide spectrum and the spastic paraparesis phenotype in autosomal dominant Alzheimer's diseaseKatarzyna Marta Zoltowska, Julia Bandera, Mohamed Belal Hamed, et al.
The EMBO Journal|September 19, 2022
Enzyme-substrate interface targeting by imidazole-based γ-secretase modulators activates γ-secretase and stabilizes its interaction with APPDieter Petit, Manuel Hitzenberger, Matthias Koch, et al.
Analytical Chemistry|November 3, 2020
Computational Analysis of Alzheimer Amyloid Plaque Composition in 2D- and Elastically Reconstructed 3D-MALDI MS ImagesThomas Enzlein, Jonas Cordes, Bogdan Munteanu, et al.
Molecular Psychiatry|April 2, 2022
Aβ profiles generated by Alzheimer's disease causing PSEN1 variants determine the pathogenicity of the mutation and predict age at disease onsetDieter Petit, Sara Gutiérrez Fernández, Katarzyna Marta Zoltowska, et al.
Analytical Chemistry|September 2, 2020
Direct Automated MALDI Mass Spectrometry Analysis of Cellular Transporter Function: Inhibition of OATP2B1 Uptake by 294 DrugsMelissa S Unger, Lena Schumacher, Thomas Enzlein, et al.
Science Advances|June 17, 2021
Following spatial Aβ aggregation dynamics in evolving Alzheimer's disease pathology by imaging stable isotope labeling kineticsWojciech Michno, Katie M Stringer, Thomas Enzlein, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 16, 2026
Multiplexed spatial screening of extrahepatic lipid-based nanoparticles for in vivo messenger RNA targetingThomas Enzlein, Jens Schumacher, Alexander Geisel, et al.
Biorxiv : the Preprint Server for Biology|August 14, 2023
Alzheimer's disease linked Aβ42 exerts product feedback inhibition on γ-secretase impairing downstream cell signalingKatarzyna Marta Zoltowska, Utpal Das, Sam Lismont, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 17, 2025
From Sample to Mixed Reality: A Translational 3D MALDI Imaging Platform for Advanced 3D Spatial Omics Analysis of 3D Cell Culture Disease ModelsStefania Alexandra Iakab, Jonas Cordes, Thomas Enzlein, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
The EMBO Journal|October 19, 2023
APP substrate ectodomain defines amyloid-β peptide length by restraining γ-secretase processivity and facilitating product releaseMatthias Koch, Thomas Enzlein, Shu-Yu Chen, et al.
Alzheimer'S Research & Therapy|November 27, 2025
The relationship between amyloid-β peptide spectrum and the spastic paraparesis phenotype in autosomal dominant Alzheimer's diseaseKatarzyna Marta Zoltowska, Julia Bandera, Mohamed Belal Hamed, et al.
The EMBO Journal|September 19, 2022
Enzyme-substrate interface targeting by imidazole-based γ-secretase modulators activates γ-secretase and stabilizes its interaction with APPDieter Petit, Manuel Hitzenberger, Matthias Koch, et al.
Analytical Chemistry|November 3, 2020
Computational Analysis of Alzheimer Amyloid Plaque Composition in 2D- and Elastically Reconstructed 3D-MALDI MS ImagesThomas Enzlein, Jonas Cordes, Bogdan Munteanu, et al.
Molecular Psychiatry|April 2, 2022
Aβ profiles generated by Alzheimer's disease causing PSEN1 variants determine the pathogenicity of the mutation and predict age at disease onsetDieter Petit, Sara Gutiérrez Fernández, Katarzyna Marta Zoltowska, et al.
Analytical Chemistry|September 2, 2020
Direct Automated MALDI Mass Spectrometry Analysis of Cellular Transporter Function: Inhibition of OATP2B1 Uptake by 294 DrugsMelissa S Unger, Lena Schumacher, Thomas Enzlein, et al.
Science Advances|June 17, 2021
Following spatial Aβ aggregation dynamics in evolving Alzheimer's disease pathology by imaging stable isotope labeling kineticsWojciech Michno, Katie M Stringer, Thomas Enzlein, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 16, 2026
Multiplexed spatial screening of extrahepatic lipid-based nanoparticles for in vivo messenger RNA targetingThomas Enzlein, Jens Schumacher, Alexander Geisel, et al.
Biorxiv : the Preprint Server for Biology|August 14, 2023
Alzheimer's disease linked Aβ42 exerts product feedback inhibition on γ-secretase impairing downstream cell signalingKatarzyna Marta Zoltowska, Utpal Das, Sam Lismont, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 17, 2025
From Sample to Mixed Reality: A Translational 3D MALDI Imaging Platform for Advanced 3D Spatial Omics Analysis of 3D Cell Culture Disease ModelsStefania Alexandra Iakab, Jonas Cordes, Thomas Enzlein, et al.
Pageof 3